Belamcanda chinensis extract inhibits non-small cell lung cancer proliferation and induces apoptosis via inhibiting the MAPK (Ras/Raf) and Akt pathways.
BCE from traditional Chinese medicine inhibits NSCLC cell growth by inducing apoptosis and blocking key signaling pathways, suggesting potential as a treatment for NSCLC, particularly in patients with Ras or Raf mutations.
- Ma C et al (2024).
- Heliyon.
- PubMed:
- 39229537